Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation TCT 2024

Role of Viability Testing to Guide Multivessel PCI With LV Dysfunction in 2024

Presenter: Robert Bonow

October 29, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Daily News

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Caitlin E. Cox

February 09, 2024

News Daily News

Revamped AUC in Chronic Coronary Disease Reflect Changing Practice

L.A. McKeown

June 02, 2023

News Conference News ACC 2023

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

L.A. McKeown

March 09, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Daily News

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

Shelley Wood

August 11, 2022

News Daily News

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Yael L. Maxwell

December 13, 2021

News Daily News

Korean Registry Casts Fresh Light on Late STEMI Care, Outcomes

Shelley Wood

April 13, 2021

News Daily News

Long-term CTO Data Raise Questions Over Primary Goals of Care

Yael L. Maxwell

February 08, 2021

News Daily News

PCI of a Last Remaining Patent Vessel Is Rare and Risky, UK Data Confirm

Todd Neale

September 08, 2020

News Daily News

STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects

Todd Neale

August 21, 2019

Presentation Controversies and Advances 2018

Does Myocardial Viability Predict Improvement With Revascularization?

Presenter: Robert O. Bonow

November 16, 2018

News Conference News SCAI 2018

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

Yael L. Maxwell

April 26, 2018

Presentation CHIP Seattle 2017

How to Assess Viability and Does It Matter

Presenter: Eric V. Krieger

August 10, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Daily News

On the Frontier of CTO PCI for STEMI Patients: Answers Lead to More Questions in EXPLORE

Yael L. Maxwell

October 05, 2016

News Daily News

Leaving Significant Stenoses Untreated After PCI May Worsen 1-Year Outcomes: SCAAR Data

Todd Neale

February 01, 2016

Advertisement

Role of Viability Testing to Guide Multivessel PCI With LV Dysfunction in 2024

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Revamped AUC in Chronic Coronary Disease Reflect Changing Practice

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

What’s Going to Be Hot at ACC/WCC 2023?

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Korean Registry Casts Fresh Light on Late STEMI Care, Outcomes

Long-term CTO Data Raise Questions Over Primary Goals of Care

PCI of a Last Remaining Patent Vessel Is Rare and Risky, UK Data Confirm

STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects

Does Myocardial Viability Predict Improvement With Revascularization?

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

How to Assess Viability and Does It Matter

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

On the Frontier of CTO PCI for STEMI Patients: Answers Lead to More Questions in EXPLORE

Leaving Significant Stenoses Untreated After PCI May Worsen 1-Year Outcomes: SCAAR Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content